Anti-retroviral Flashcards
1
Q
General Guideline for HIV management in Treatment of Naive patient:
A
Add Tenofovir/Emtricitabine to ALL
Truvada=Tenofovir/Emtricitabine
RTV=los-dose ritonavir as boosting agent
- NNRTI-based backbone
- Efavirenz (alternative choice)
- PI-based backbone
- Darunavir + RTV
- first choice
- Atazanavir + RTV
- alternative choice
- Darunavir + RTV
- INSTI-based backbone:
- Dolutegravir
- first choice
- Raltegravir
- first choice
- Dolutegravir
Pregnant Patient:
- Lopinavir/ritonavir +
- zidovudine/lamivudine
- abacavir/lamivudine
- tenfovoir/emtricitabine
2
Q
5 classes of HIV drugs:
A
- Drugs that inhibit enzymes need for HIV replication:
- Reverse Transcriptase Inhibitors:
- Nucleoside (NRTIs)
- aka nukes
- block reverse transcription
- Non-Nucleoside (NNRTIs)
- aka non-nuke
- block reverse transcription
- Nucleoside (NRTIs)
- Protease Inhibitors (PI)
- block budding
- Integrase Strand Transfer Inhibitors (ISTI)
- block integration
- Reverse Transcriptase Inhibitors:
- Drugs that inhibit viral entry into host cell:
- CCR5 antagonists
- block binding
- Fusion Inhibitor
- block fusion and uncoating
- CCR5 antagonists
3
Q
HAART
A
Combination of 3 drugs:
- 2 nukes +
- 1 PI
- 1 Non-nuke
- 1 integrase I
4
Q
Preferred Regimen for Treatment of Naive Patients:
A
All have Tenofovir/emtricitabine=Truvada
- Efavirenz
- Atazanavir (boosted)
- RTV=boost
- Darunavir (boosted)
- RTV=boost
- Raltegravir
5
Q
NRTIs: General Features
- MOA
- PK
- side effects
A
- MOA:
- nucleoside/tide analog
- require intracellular activation (phosphorylation)
- Inhibit HIV-1 reverse transcriptase
- decrease replication in infected cells
- Incorporated into viral DNA causing early chain termination
- PK
- not metabolized by CYPs
- Side effects:
- cause lactic acidosis w/hepatic steatosis (rare but fatal)
6
Q
NRTIs: Drugs
A
- Emtricitabine
- 1st line treatment of naive pt (+tenofovir DF)
- well tolerated but hyperpigmentation of palms and soles
- Tenofovir Disoproxil Fumurate
- 1st line for:
- treatment of naive pt (+ emtricitabine)
- HIV/HBV co-infected
- 1st line for:
- Abacavir & Lamivudine
- alternate backbone
7
Q
NNRTIs: General Features
- MOA
- PK
- Side effects
A
- MOA:
- Direct non-nucleoside inhibitors of HIV-1 reverse transcriptase
- inhibit HIV-1 reverse transcriptase
- decrease replication
- Incorporate into viral DNA causing early chain termination
- inhibit HIV-1 reverse transcriptase
- No used as monotherapy bc resistance develops rapidly
- Direct non-nucleoside inhibitors of HIV-1 reverse transcriptase
- PK
- metabolized by hepatic CYPs
- many DDIs
- metabolized by hepatic CYPs
- Side effects:
- Elevated Liver Function Enzymes
- hypersensitivity reactions (Rash)
8
Q
NNRTIs: Drugs
A
- Efavirenz (most important)
- 1st line NNRTI for treatment of naive
- Side effects:
- rash
- diarrhea
- insomnia
- nightmares
- dyslipidemia
- tertogenecity
- Pregnancy Category D
- Substrate, inhibitor, & inducer of CYP3A4
- Rilpivirine
- Etravirine
- Nevirapine
- Delaviridine
9
Q
A
10
Q
PIs: General
- MOA
- PK
- side effects
A
- MOA
- prevent the HIV protease enzyme from cleaving the polypeptide (and structural proteins) into mature infectious particles
- All PIs bind reversibly to active site of the enzyme
- PK
- all extensively metabolized by CYP3A4
- Side effects:
- Hyperlipidemia
- Fat malditribution
- Hyperglycemia
- Insulin Resistance
- Breast enlargement
- except atazanavir
11
Q
PIs: Drugs
A
-navir
- Ritonavir
- potent CYP3A4 inhibitor
- Never administered alone
- Used at low doses to “boost” plasma levels of other PIs
- increase metabolism of other PIs
- Atazanavir
- 1st line PI for treatment of naive
- boosted with ritonavir
- alternate choice
- One of the most used
- can cause changes in heart rythm=prolong PR
- 1st line PI for treatment of naive
- Darunavir
- 1st line PI for treatment of naive
- boosted with RTV
- first choice
- Developed specifically for resistant HIV;
- allergic to sulfa-dont give; similar to sulfa
- one of the most used
- 1st line PI for treatment of naive
- Lopinavir:
- 1st line PI for treatment of naive pregnant women
- boosted with RTV
- 1st line PI for treatment of naive pregnant women
12
Q
A
13
Q
Rifampin
A
- Major TB drug
- Increases drug metabolizing enzymes
- Decrease the blood levels of NNRTIs and PIs
- not therapeutic anymore
- Subtherapeutic resistance
14
Q
ISTI: General:
-MOA
A